| # | Ticker | Company | Price | Chg % | Mkt Cap | P/E | EPS Growth TTM | Div Yield | Sector | Return 1Y | Revenue Growth… | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals Incorporated | $427.65 | 0.8% | $108.78B | 27.9 | 530.1% | — | Healthcare | -5% | 10.4% | ||
| 2 | Ascendis Pharma A/S | $235.90 | 4.7% | $14.48B | -55.5 | 39.8% | — | Healthcare | 44.9% | 97.4% | ||
| 3 | BridgeBio Pharma, Inc. | $68.09 | -1% | $13.26B | -18.0 | -33% | — | Healthcare | 84.3% | 126.3% | ||
| 4 | BioMarin Pharmaceutical Inc. | $54.60 | 2.6% | $10.5B | 30.3 | -48.3% | — | Healthcare | -8.5% | 9.9% | ||
| 5 | Cogent Biosciences, Inc. | $35.85 | -3.1% | $5.82B | -14.1 | -27.5% | — | Healthcare | 662.8% | — | ||
| 6 | Corcept Therapeutics Incorporated | $52.15 | 1.6% | $5.6B | 63.6 | -69.8% | — | Healthcare | -26.3% | 12.2% | ||
| 7 | Mirum Pharmaceuticals, Inc. | $110.08 | 4% | $5.53B | -234.2 | -745.9% | — | Healthcare | 168.5% | 8% | ||
| 8 | PTC Therapeutics, Inc. | $66.61 | 2.4% | $5.52B | 8.6 | 263.6% | — | Healthcare | 84.1% | 114.5% | ||
| 9 | Amicus Therapeutics, Inc. | $14.49 | 0% | $4.47B | -80.5 | 87% | — | Healthcare | 134.1% | 21.3% | ||
| 10 | Crinetics Pharmaceuticals, Inc. | $41.71 | 2.4% | $4.37B | -8.4 | -33.4% | — | Healthcare | 36.7% | 421.7% | ||
| 11 | Travere Therapeutics, Inc. | $44.77 | -0.1% | $4.16B | -79.9 | 81.1% | — | Healthcare | 124.4% | 96% | ||
| 12 | Edgewise Therapeutics, Inc. | $36.99 | -2.7% | $3.97B | -22.7 | -12.4% | — | Healthcare | 157.2% | — | ||
| 13 | Catalyst Pharmaceuticals, Inc. | $30.52 | -1.1% | $3.74B | 18.2 | 28.2% | — | Healthcare | 32.4% | 19.8% | ||
| 14 | Soleno Therapeutics, Inc. | $52.94 | 0% | $2.76B | 135.7 | 105.3% | — | Healthcare | -28.2% | — | ||
| 15 | Disc Medicine, Inc. | $68.65 | 1.6% | $2.62B | -11.4 | -50.6% | — | Healthcare | 61.2% | — | ||
| 16 | Ultragenyx Pharmaceutical Inc. | $25.93 | 3.7% | $2.55B | -4.4 | -3.9% | — | Healthcare | -26% | 13.3% | ||
| 17 | Pharvaris N.V. | $30.11 | 0.3% | $1.96B | -10.3 | -19.2% | — | Healthcare | 78.9% | — | ||
| 18 | Sionna Therapeutics, Inc. | $43.29 | 5.7% | $1.94B | -23.0 | — | — | Healthcare | 239.3% | — | ||
| 19 | Harmony Biosciences Holdings, Inc. | $32.78 | 1.4% | $1.89B | 12.1 | 8% | — | Healthcare | 2.3% | 21.5% | ||
| 20 | BioCryst Pharmaceuticals, Inc. | $8.83 | -2.2% | $1.85B | 7.3 | -585.1% | — | Healthcare | -14% | 75.9% | ||
| 21 | Agios Pharmaceuticals, Inc. | $26.98 | -0.8% | $1.6B | -3.8 | -164.2% | — | Healthcare | -4.7% | 78.3% | ||
| 22 | Palvella Therapeutics, Inc. | $130.17 | 0.5% | $1.54B | -35.1 | 33.2% | — | Healthcare | 467.7% | -100% | ||
| 23 | Pharming Group N.V. | $16.40 | 1.4% | $1.15B | 410.0 | 122.7% | — | Healthcare | 81.2% | 26.5% | ||
| 24 | Xeris Biopharma Holdings, Inc. | $6.37 | 2.2% | $1.1B | 1990.6 | 97.9% | — | Healthcare | 48.1% | 43.7% | ||
| 25 | Savara Inc. | $5.27 | 0.4% | $911M | -11.0 | -25.7% | — | Healthcare | 75.7% | — | ||
| 26 | Eton Pharmaceuticals, Inc. | $30.15 | -0.8% | $815M | -177.4 | -12.7% | — | Healthcare | 81.3% | 104.9% | ||
| 27 | Astria Therapeutics, Inc. | $12.58 | 0% | $718M | -7.5 | -2.4% | — | Healthcare | 187.9% | — | ||
| 28 | Zevra Therapeutics, Inc. | $11.25 | 6% | $665M | 8.3 | 166.8% | — | Healthcare | 52% | 350.9% | ||
| 29 | X4 Pharmaceuticals, Inc. | $4.38 | 4.3% | $553M | -2.3 | -313.1% | — | Healthcare | 36% | -71.3% | ||
| 30 | Keros Therapeutics, Inc. | $11.78 | 0.1% | $438M | 5.1 | 143.2% | — | Healthcare | -14.4% | 6775% | ||
| 31 | Fulcrum Therapeutics, Inc. | $7.11 | 1.3% | $385M | -6.0 | -1542.9% | — | Healthcare | 32.9% | -100% | ||
| 32 | Larimar Therapeutics, Inc. | $4.15 | 3.5% | $355M | -1.8 | -70% | — | Healthcare | 97.6% | — | ||
| 33 | Protalix BioTherapeutics, Inc. | $2.02 | 3.1% | $162M | -24.0 | -387% | — | Healthcare | -26% | -1.2% | ||
| 34 | Rallybio Corporation | $14.56 | 3.3% | $82M | -1.4 | 79.7% | — | Healthcare | 511.8% | -18.4% | ||
| 35 | Spruce Biosciences, Inc. | $57.87 | -2.5% | $79M | -1.1 | 46% | — | Healthcare | 985.7% | -100% | ||
| 36 | Mereo BioPharma Group plc | $0.24 | -13.4% | $38M | -0.9 | 100% | — | Healthcare | -89.8% | — | ||
| 37 | Grace Therapeutics, Inc. | $2.37 | 1.7% | $37M | -3.0 | 70.7% | — | Healthcare | -19.7% | — | ||
| 38 | Applied Therapeutics, Inc. | $0.10 | 0% | $15M | -0.1 | 93.6% | — | Healthcare | -74.7% | 573.9% | ||
| 39 | Cadrenal Therapeutics, Inc. Common Stock | $6.17 | -2.4% | $13M | -0.7 | -10% | — | Healthcare | -60.7% | — | ||
| 40 | Quoin Pharmaceuticals, Ltd. | $6.43 | -0.2% | $10M | -0.1 | -59% | — | Healthcare | 3.7% | — | ||